Valeant Pharmaceuticals International, Inc. (NYSE) (VRX)
1 member of Congress has disclosed 4 trades in Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) since 2014: 3 buys and 1 sale. The most recent was disclosed on Jul 20, 2015.
- Trades disclosed
- 4
- Members trading
- 1
- Buys / sells
- 3 / 1
- Reported value
- $4K–$60K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at VRX
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded VRX
- Sen. Susan M. Collins (R-ME)3 buys · 1 sale31Jul 20, 2015
All trades
- Jul 20, 2015$1K–$15K
Sen. Susan M. Collins (R-ME)
Bought Valeant Pharmaceuticals International, Inc. (NYSE) VRX
$1K–$15K · Traded Mar 11, 2014 · disclosed Jul 20, 2015 · Spouse · filed 496 days later
- May 13, 2015$1K–$15K
Sen. Susan M. Collins (R-ME)
Bought Valeant Pharmaceuticals International, Inc. (NYSE) VRX
$1K–$15K · Traded Mar 11, 2014 · disclosed May 13, 2015 · Spouse · filed 428 days later
- May 16, 2014$1K–$15K
Sen. Susan M. Collins (R-ME)
Sold (full) Valeant Pharmaceuticals International, Inc. (NYSE) VRX
$1K–$15K · Traded May 7, 2014 · disclosed May 16, 2014 · Spouse
- Mar 19, 2014$1K–$15K
Sen. Susan M. Collins (R-ME)
Bought Valeant Pharmaceuticals International, Inc. (NYSE) VRX
$1K–$15K · Traded Mar 11, 2014 · disclosed Mar 19, 2014 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.